119.42CHF-0.05%Mkt Cap: 232.13B CHFP/E: 21.21Last update: 2026-05-21
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…
Industry Peers
Pharmaceuticalsloading…
Indicators:|
Key Statistics
Company
Market Cap232.13B CHF
Enterprise Value265.18B CHF
Revenue (TTM)56.58B CHF
Gross Profit42.98B CHF
Net Income (TTM)13.98B CHF
Revenue/Share29.40 CHF
Last Price119.42 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75.3K
CountryCH
SectorHealth Care
IndustryPharmaceuticals
ISINCH0012005267
Valuation
P/E (Trailing)21.21
P/E (Forward)—
PEG—
EV/EBITDA11.57
EV/Revenue4.69
P/S4.05
P/B6.24
EPS (TTM)5.63
EPS (Forward)—
52W Range
108.8471% of range123.70
52W High123.70 CHF
52W Low108.84 CHF
Profitability
Gross Margin75.83%
Oper. Margin30.48%
EBITDA Margin40.51%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth-0.70%
Earnings Growth-9.30%
Cash Flow & Leverage
Operating CF19.14B CHF
CapEx (TTM)3.90B CHF
FCF Margin21.25%
FCF Yield5.18%
Net Debt40.11B CHF
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.77
Current Ratio0.85
Quick Ratio0.53
Book Value/Sh18.88 CHF
Cash/Share3.612 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate4.666 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.0
Float1.82B
Insiders—
Institutions—
Technical
SMA 50117.47 (+1.7%)
SMA 200117.47 (+1.7%)
Beta0.49
S&P 52W Chg24.23%
Avg Vol (30d)129.98K
Avg Vol (10d)130.00K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—